Cargando…
Fresh Surgical Specimens Yield Breast Stem/Progenitor Cells and Reveal Their Oncogenic Abnormalities
BACKGROUND: The process by which breast cancer stem cells arise is unknown. It may be that the benign stem cells in breast tissue are transformed into malignant stem cells through the acquisition of genetic abnormalities. In this study, we collected and compared benign and malignant breast stem/prog...
Autores principales: | Pommier, SuEllen J., Hernandez, Ariel, Han, Esther, Massimino, Kristen, Muller, Patrick, Diggs, Brian, Chamberlain, Erin, Murphy, Jennifer, Hansen, Juliana, Naik, Arpana, Vetto, John, Pommier, Rodney F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3264874/ https://www.ncbi.nlm.nih.gov/pubmed/21748247 http://dx.doi.org/10.1245/s10434-011-1892-z |
Ejemplares similares
-
Estrogen receptor, progesterone receptor, interleukin-6 and interleukin-8 are variable in breast cancer and benign stem/progenitor cell populations
por: Schillace, Robynn V, et al.
Publicado: (2014) -
Gene expression signatures of breast cancer stem and progenitor cells do not exhibit features of Warburg metabolism
por: Gordon, Nicole, et al.
Publicado: (2015) -
Comparison of breast cancer incidence, clinicopathologic features, and risk factor prevalence in women aged 20‐29 at diagnosis to those aged 30‐39
por: Limbach, Kristen E., et al.
Publicado: (2020) -
Pathology Examination of Breast Reduction Specimens: Dispelling the Myth
por: Fisher, Mark, et al.
Publicado: (2020) -
Time Trends in Histopathological Findings in Mammaplasty Specimens in a Dutch Academic Pathology Laboratory
por: Stutterheim, Hannah W., et al.
Publicado: (2023)